Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Rare Disease Gene Therapy Guidance Gives More Flexibility On Placebo-Controlled Trials
Feb 27 2020
•
By
Sue Sutter
Rare diseases are the focus of one of six gene therapy final guidances from the US FDA. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Cell & Gene Therapies
More from Advanced Technologies